86
Views
16
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes and Concomitant Disorders

Use of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

, MD, MSc
Pages 138-144 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

André J Scheen. (2015) Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes. Expert Opinion on Drug Safety 14:4, pages 505-524.
Read now
André J Scheen. (2015) A review of gliptins for 2014. Expert Opinion on Pharmacotherapy 16:1, pages 43-62.
Read now
André J Scheen. (2013) Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease. Expert Opinion on Drug Metabolism & Toxicology 9:5, pages 529-550.
Read now
André J Scheen. (2013) Efficacy and safety of Jentadueto® (linagliptin plus metformin). Expert Opinion on Drug Safety 12:2, pages 275-289.
Read now

Articles from other publishers (12)

Bashir Usman, Neha Sharma, Saurabh Satija, Meenu Mehta, Manish Vyas, Gopal L. Khatik, Navneet Khurana, Philip M. Hansbro, Kylie Williams & Kamal Dua. (2019) Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. Current Pharmaceutical Design 25:23, pages 2510-2525.
Crossref
Fernando Gomez-Peralta, Cristina Abreu, Sara Gomez-Rodriguez, Rafael J. Barranco & Guillermo E. Umpierrez. (2018) Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios. Diabetes Therapy 9:5, pages 1775-1789.
Crossref
Thinzar Min, Gareth I. Davies, Sam Rice, James Chess & Jeffrey W. Stephens. (2018) Treatment choices for the glycaemic management of patients with type 2 diabetes and chronic kidney disease: Analysis of the SAIL patient linked dataset. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:2, pages 123-127.
Crossref
Bansal Beena. (2017) Management of type 2 Diabetes in patients with Chronic Kidney Disease. Archives of Clinical Nephrology, pages 053-056.
Crossref
Natasha Jacques & Indranil Dasgupta. (2016) Management of chronic kidney disease and diabetes: a case study. Journal of Kidney Care 1:1, pages 12-17.
Crossref
André J. Scheen. (2014) Pharmacokinetics and Clinical Use of Incretin-Based Therapies in Patients with Chronic Kidney Disease and Type 2 Diabetes. Clinical Pharmacokinetics 54:1, pages 1-21.
Crossref
Brian Bostick, Javad Habibi, Lixin Ma, Annayya Aroor, Nathan Rehmer, Melvin R. Hayden & James R. Sowers. (2014) Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesity. Metabolism 63:8, pages 1000-1011.
Crossref
Miyako Kishimoto & Mitsuhiko Noda. (2014) Glucose management in diabetic patients undergoing hemodialysis. Diabetology International 5:2, pages 84-91.
Crossref
Nasser Mikhail. (2014) Who would really benefit from DPP-4 inhibitors?. Endocrine 46:1, pages 6-7.
Crossref
Ricardo Gómez-Huelgas, Alberto Martínez-Castelao, Sara Artola, José Luis Górriz & Edelmiro Menéndez. (2014) Tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal crónica. Medicina Clínica 142:2, pages 85.e1-85.e10.
Crossref
Vecihi Batuman. 2014. Diabetes and Kidney Disease. Diabetes and Kidney Disease 241 250 .
Junghyun Noh. (2013) Glycemic Control in Diabetic Patients with Diabetic Nephropathy. The Journal of Korean Diabetes 14:1, pages 23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.